Page last updated: 2024-10-21

5-dimethylamiloride and Cystic Fibrosis

5-dimethylamiloride has been researched along with Cystic Fibrosis in 1 studies

5-dimethylamiloride: has anti-HIV-1 activity

Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdullah, LH1
Evans, JR1
Wang, TT1
Ford, AA1
Makhov, AM1
Nguyen, K1
Coakley, RD1
Griffith, JD1
Davis, CW1
Ballard, ST1
Kesimer, M1

Other Studies

1 other study available for 5-dimethylamiloride and Cystic Fibrosis

ArticleYear
Defective postsecretory maturation of MUC5B mucin in cystic fibrosis airways.
    JCI insight, 2017, 03-23, Volume: 2, Issue:6

    Topics: Amiloride; Animals; Bronchi; Bumetanide; Cells, Cultured; Cystic Fibrosis; Humans; In Vitro Techniqu

2017